NGT BioPharma Consultants provides a range of Early Development advisory and educational services bolstering client efforts to access the financial resources needed to advance their valuable assets towards Phase 1 clinical trials and beyond.

Our experienced team of project leaders and managers with expertise in small and large molecules (Mabs, duobodies, proteins, cell therapy, gene therapy as well as new modalities), work across all stages of development to efficiently integrate the critical stage appropriate workstreams to ensure maximum acceleration of client assets to the next milestone.